Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Khaled Yazji"'
Autor:
Tim Kinnaird, Mehmood Butt, Fairoz Abdul, Khaled Yazji, Ahmed Hailan, Sean Gallagher, Nicholas Ossei-Gerning, Alexander Chase, Anirban Choudhury, David Smith, Richard Anderson
Publikováno v:
PLoS ONE, Vol 11, Iss 6, p e0157812 (2016)
INTRODUCTION:Prolonged dual anti-platelet therapy (DAPT) may cause excess bleeding in certain patients. The biolimus-A9 drug-coated stent (BA9-DCS) has a rapid drug-elution profile allowing shortened DAPT. Data were gathered on the early experience i
Externí odkaz:
https://doaj.org/article/b4f128af2cc247d6aff5cf88f512bc9c
Autor:
Tim Kinnaird, Sean Gallagher, Peter O'Kane, Khaled Yazji, Ahmed Hailan, Azeem S Sheikh, Senthil Elangovan, Anirban Choudhury, Richard Anderson, Fairoz Abdul, Adnan Yousef, David J. Smith, Jonathan Hinton
Publikováno v:
Catheterization and Cardiovascular Interventions. 92:1220-1228
INTRODUCTION Prolonged dual anti-platelet therapy (DAPT) is undesirable in certain patients. The biolimus-A9 drug-coated stent (BA9-DCS) has a rapid drug-elution profile allowing shortened DAPT. METHODS The demographics, procedural data, and clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70c7adc8528f7fae9c2caa82896e890d
https://doi.org/10.1002/ccd.27722
https://doi.org/10.1002/ccd.27722
Autor:
Tim Kinnaird, Richard Anderson, Senthil Elangovan, Khaled Yazji, Muhammad Z. Ul Haq, Nick Ossei-Gerning, Fairoz Abdul, Keith Morris
Publikováno v:
Journal of Interventional Cardiology. 30:491-499
Objectives To define more clearly the associations between baseline anemia, bleeding/ischemia risk, coronary disease severity, and outcomes by revascularization completeness. Background Anemia is associated with adverse outcomes in patients presentin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc57f4e773401134d2e1eb16c55ea37e
https://doi.org/10.1111/joic.12406
https://doi.org/10.1111/joic.12406
Autor:
Tim Kinnaird, Anirban Choudhury, Richard Anderson, Senthil Elangovan, James Cockburn, Mamas A. Mamas, Fairoz Abdul, Nick Ossei-Gerning, Khaled Yazji
Publikováno v:
The American Journal of Cardiology. 118:1164-1170
Although randomized trial data suggest that complete revascularization improves outcomes after percutaneous coronary intervention (PCI), the impact of differing revascularization strategies in octogenarians is not well defined. We performed a retrosp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91b2a836bec4e1821de64082b78bda61
https://doi.org/10.1016/j.amjcard.2016.07.031
https://doi.org/10.1016/j.amjcard.2016.07.031
Autor:
Mehmood Butt, M B Khaled Yazji, Anirban Choudhury, M B Laurence Thornhill, Rito Mitra, Nicholas Ossei-Gerning, Tim Kinnaird, Richard Anderson
Publikováno v:
Journal of Interventional Cardiology. 29:129-136
Background Prolonging infusions may abrogate the acute stent thrombosis (ST) associated with bivalirudin use during primary PCI but at an increased cost. We hypothesized that continuing the bivalirudin infusion commenced during the procedure at the P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b0fdedc4eaed799013fe905698e4110e
https://doi.org/10.1111/joic.12280
https://doi.org/10.1111/joic.12280
Autor:
Tim, Kinnaird, Khaled, Yazji, Laurence, Thornhill, Mehmood, Butt, Nicholas, Ossei-Gerning, Anirban, Choudhury, Rito, Mitra, Richard, Anderson
Publikováno v:
Journal of interventional cardiology. 29(2)
Prolonging infusions may abrogate the acute stent thrombosis (ST) associated with bivalirudin use during primary PCI but at an increased cost. We hypothesized that continuing the bivalirudin infusion commenced during the procedure at the PCI recommen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6424f8de55ee841000acd3bfe28f1f15
https://pubmed.ncbi.nlm.nih.gov/26822753
https://pubmed.ncbi.nlm.nih.gov/26822753
Autor:
Anirban Choudhury, Richard Anderson, Tim Kinnaird, Sean Gallagher, Mehmood Butt, Khaled Yazji, Nicholas Ossei-Gerning, Ahmed Hailan, Fairoz Abdul, Alexander Chase, David R. Smith
Publikováno v:
PLoS ONE, Vol 11, Iss 6, p e0157812 (2016)
PLoS ONE
PLoS ONE
Introduction Prolonged dual anti-platelet therapy (DAPT) may cause excess bleeding in certain patients. The biolimus-A9 drug-coated stent (BA9-DCS) has a rapid drug-elution profile allowing shortened DAPT. Data were gathered on the early experience i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e52e4826cd07a5751e242f695bb5a52
http://europepmc.org/articles/PMC4928951?pdf=render
http://europepmc.org/articles/PMC4928951?pdf=render
Autor:
Tim Kinnaird, Sorayya Kakhi, Anirban Choudhury, Richard Anderson, Nick Ossei-Gerning, Khaled Yazji
Publikováno v:
The American journal of cardiology. 116(3)
Patients treated with warfarin who undergo percutaneous coronary intervention (PCI) present a difficult therapeutic problem. Their baseline demographics, procedural characteristics, and 12-month outcomes are poorly defined. We conducted a retrospecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fc8e4c704fd1c7a57017cf3b0115c17
https://pubmed.ncbi.nlm.nih.gov/26048850
https://pubmed.ncbi.nlm.nih.gov/26048850
Autor:
Alex Chase, Tim Kinnaird, Nick Ossei-Gerning, Khaled Yazji, Mehmood Butt, Dave Smith, Richard A. Anderson, Fairoz Abdul
Publikováno v:
Heart. 102:A11.3-A11
Background Prolonged DAPT is undesirable in some patients. A biolimus-A9 drug-coated stent (BA9-DCS) has a rapid drug-elution profile potentially allowing shortened DAPT. Methods Data were gathered prospectively for 410 patients deemed to be at high
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8cf5ce6cb414b2631f258144f3ac9fcb
https://doi.org/10.1136/heartjnl-2016-309588.23
https://doi.org/10.1136/heartjnl-2016-309588.23
Autor:
Tim Kinnaird, Sorayya Kakhi, Anirban Choudhury, Richard A. Anderson, Khaled Yazji, Nick Ossei-Gerning
Publikováno v:
Heart. 102:A12.1-A12
Introduction Patients treated with warfarin who undergo percutaneous coronary intervention (PCI) present a difficult therapeutic problem. Their baseline demographics, procedural characteristics and 12-month outcomes are poorly defined. Methods We con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6a470568c9bc94bbbd85a792f0c845cc
https://doi.org/10.1136/heartjnl-2016-309588.25
https://doi.org/10.1136/heartjnl-2016-309588.25